Baricitinib Tablets.

Effects and efficacy:
Baricitinib is indicated for adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately or are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). Baricitinib can be used in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs.
Dosage and administration:
The recommended dose of baricitinib is 2 mg once daily. For the following groups, 4 mg once daily may be considered: (1) For adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately or are intolerant to conventional disease-modifying antirheumatic drugs (csDMARDs), it is recommended to start treatment with 2 mg once daily, and the response is still inadequate after 3 months of treatment, or (2) Patients with inadequate response to tumor necrosis factor inhibitors (TNFi-IR). Oral administration can be done with or without meals and can be taken at any time of the day.
Contraindications:
Allergy to this product is contraindicated. Contraindicated during pregnancy. Use with caution in patients with liver function impairment. Use with caution in patients with renal function impairment.
Related dosage forms:
Baricitinib tablets